Merge hemo displays, measures, and records physiological data from a patient undergoing a cardiac catheterization procedure.The hemo system can visualize and capture vital sign values including ecg, impedance respiration, spo2 and pleth waveforms, invasive blood pressure, temperature, non-invasive blood pressure (nibp), thermodilution cardiac output and fractional flow reserve (ffr).The system can display and capture diagnostic quality 12 lead resting ecg to visualize arrhythmias, and st-segment changes.Some hemo systems have an option to measure and display side-stream end tidal carbon dioxide (etco2) along with apnea and respiration rates calculated from the etco2 waveform.The hemodynamic portion of the system is comprised of the patient data module (pdm) and the merge hemo monitor pc.The two units are connected via a serial interface.All vital parameters are acquired and calculated in the pdm.This data is then transmitted to the merge hemo monitor pc via the serial interface.All data can then be displayed on the merge hemo monitor pc.The merge hemo system is not intended to produce alarms for out-of-range conditions.Patient allergies and current medication information can be entered by the user and displayed by the system.If desired and using a third party database the hemo system can display drug to drug or drug to allergy interaction information.The system is intended for use in hospital cardiac catheterization laboratories and in pre-and post-procedure care areas in the hospital under the close supervision of qualified medical personnel.On (b)(6) 2021, a customer reported that a hemo ups (universal power supply) had caught fire and melted and the customer needed a replacement sent.Merge healthcare technical support confirmed that no patient was involved when this took place.Merge healthcare technical support has requested the ups in question to be sent back, and has sent a replacement as well as 2 power strips.The ups in question will be reviewed and a supplemental report will be filed when more information becomes available.This has the potential to delay patient treatment and/or diagnosis.There have been no reports of patient injury or harm as a result of this issue.Reference complaints (b)(4).
|
This supplemental report is submitted to the fda in accord with applicable regulations and as indicated by merge healthcare in the initial report submitted 8/24/2021.Inspection of the unit in question showed no evidence of burning of any kind.Merge healthcare support cleaned the batteries and ran the unit for 2 weeks without problems.No further action is required.Revised information contained in this supplemental report includes the following: g6 - indication that this is follow-up report 001, h2 - indication of additional information, h6 - investigation findings: 3221 no findings available, h6 - investigation conclusions: 4309 cause traced to environment.
|